Founded in 2017 in the high-tech hub of Shenzhen, China, Shenzhen BioX Medical Co., Ltd. has rapidly emerged as a dominant force in the global molecular diagnostic analysis systems market. As a premier exporter, our mission is to bridge the gap between complex genomic science and accessible clinical application.
Our expansive 9,000 square meter facility is the heartbeat of our innovation, housing over 200 dedicated professionals, including PhD-level researchers and senior biomedical engineers. We specialize in the end-to-end development of genetic testing solutions, pathogen detection platforms, and automated laboratory equipment that meet the rigorous demands of modern medicine.
In the era of personalized healthcare, our systems enable clinicians to tailor treatments based on individual genetic profiles. From oncology biomarker analysis to rare disease screening, BioX Medical provides the accuracy required for high-stakes medical decisions.
The global demand for rapid, scalable pathogen detection has never been higher. Our RT-PCR and nucleic acid extraction platforms serve as the first line of defense in monitoring infectious diseases, supporting national health organizations in pandemic preparedness.
Beyond human health, our molecular diagnostics systems are applied in veterinary medicine and agricultural science. We provide tools for animal disease surveillance and crop genetic improvement, ensuring food security and industrial safety.
At Shenzhen BioX Medical, we don't just follow trends; we set them. Our technical roadmap for 2025-2030 focuses on three core pillars:
Developing deep-learning algorithms that can interpret complex fluorescence signals in real-time, providing predictive diagnostic insights rather than just raw data.
Reducing the diagnostic window by merging extraction, amplification, and sequencing into a single, closed-loop automated system to minimize contamination risks.
Engineering energy-efficient thermal cyclers and reducing plastic waste in consumables through biodegradable material science.
As a leading China molecular diagnostics systems exporter, we recognize the importance of localization. The IVD industry is currently navigating complex regulatory shifts, such as the EU's IVDR (In Vitro Diagnostic Regulation). BioX Medical maintains a dedicated compliance team to ensure all exported systems meet local CE, FDA, and ISO 13485 standards, providing our global partners with "peace-of-mind" logistics and legal assurance.
BioX Medical understands that a diagnostic system is only as good as the support behind it. Our global service network provides:
"In remote regions of Southeast Asia, our portable PCR systems are used for real-time monitoring of swine fever, while in European central labs, our high-throughput extractors process thousands of samples daily for routine oncology screenings."
- Head of Global Operations
A: Our combination of internal R&D, a massive 9,000sqm manufacturing base, and strict adherence to international quality standards (ISO 13485) allows us to offer premium technology at competitive global prices, coupled with comprehensive OEM services.
A: Yes, all our modern diagnostic platforms are designed with open API capabilities and HL7 protocol compatibility, ensuring seamless data integration with hospital and laboratory management software.
A: For standard systems, we maintain a robust inventory with a lead time of 2-4 weeks. Customized OEM projects typically range from 8-12 weeks depending on the complexity of the modifications.
A: We utilize advanced cold-chain logistics and validated thermal packaging. Furthermore, many of our newer molecular assays are being developed in lyophilized (freeze-dried) formats to allow for room-temperature shipping and storage.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
BioX Medical
